These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895 [TBL] [Abstract][Full Text] [Related]
6. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Krueger S; Haeckel C; Buehling F; Roessner A Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250 [TBL] [Abstract][Full Text] [Related]
8. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250 [TBL] [Abstract][Full Text] [Related]
9. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Kondraganti S; Gondi CS; Gujrati M; McCutcheon I; Dinh DH; Rao JS; Olivero WC Int J Oncol; 2006 Jul; 29(1):25-32. PubMed ID: 16773181 [TBL] [Abstract][Full Text] [Related]
10. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Tasiou A; Konduri SD; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Obeyesekere M; Rao JS Int J Oncol; 2001 Sep; 19(3):591-7. PubMed ID: 11494041 [TBL] [Abstract][Full Text] [Related]
11. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552 [TBL] [Abstract][Full Text] [Related]
12. [Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion]. Zhong R; Huang RB; Song SJ Ai Zheng; 2003 Oct; 22(10):1038-41. PubMed ID: 14558946 [TBL] [Abstract][Full Text] [Related]
13. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo. Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells. Kido A; Krueger S; Haeckel C; Roessner A Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis. Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J Med Oncol; 2010 Sep; 27(3):867-75. PubMed ID: 19763915 [TBL] [Abstract][Full Text] [Related]